Show simple item record

Poststroke Depression as a Factor Adversely Affecting the Level of Oxidative Damage to Plasma Proteins during a Brain Stroke

dc.contributor.authorCichoń, Natalia
dc.contributor.authorBijak, Michal
dc.contributor.authorMiller, Elżbieta
dc.contributor.authorNiwald, Marta
dc.contributor.authorSaluk-Bijak, Joanna
dc.date.accessioned2015-04-01T07:03:40Z
dc.date.available2015-04-01T07:03:40Z
dc.date.issued2015
dc.identifier.issn1942-0994
dc.identifier.urihttp://hdl.handle.net/11089/7593
dc.description.abstractPoststroke depression, the second most serious psychosomatic complication after brain stroke, leads to delay of the rehabilitation process and is associated with an increased disability and cognitive impairment along with increase in termmortality. Research into the biochemical changes in depression is still insufficiently described. The aim of our study was therefore to evaluate the possible association between plasma protein oxidative/nitrative damages and the development of poststroke depression. We evaluated oxidative/nitrative modifications of specific proteins by measurement of 3-nitrotyrosine and carbonyl groups levels using ELISA test. Additionally, we checked differences in proteins thiol groups by spectrophotometric assay based on reaction between DTNB and thiols. We also evaluated catalase activity in erythrocytes measured as ability to decompose H2O2. Correlation analysis was performed using Spearman’s rank. We observed significant (𝑃 < 0.001) differences in all oxidative/nitrative stress parameters in brain stroke patients compared to healthy group.Our research shows that oxidative damage of proteins is correlated with the degree of poststroke depression, while nitrative changes do not show any relationship.We demonstrate a positive correlation between the concentration of carbonyl groups and the Geriatric Depression Scale and a negative correlation between the degree of depression and the concentration of -SH groups or catalase activity.pl_PL
dc.language.isoenpl_PL
dc.publisherHindawi Publishing Corporationpl_PL
dc.relation.ispartofseriesOxidative Medicine and Cellular Longevity;Volume 2015
dc.rightsUznanie autorstwa 3.0 Polska*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/pl/*
dc.titlePoststroke Depression as a Factor Adversely Affecting the Level of Oxidative Damage to Plasma Proteins during a Brain Strokepl_PL
dc.typeArticlepl_PL
dc.contributor.authorAffiliationNatalia Cichoń - Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodzpl_PL
dc.contributor.authorAffiliationMichał Bijak - Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodzpl_PL
dc.contributor.authorAffiliationelżbieta Miller - 2Department of Physical Medicine, Medical University of Lodzpl_PL
dc.contributor.authorAffiliationMarta Niwald - 2Department of Physical Medicine, Medical University of Lodzpl_PL
dc.contributor.authorAffiliationJoanna Saluk - Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodzpl_PL
dc.referencesI.G. Li, H. Y. Han, andH. S. Lee, “Emotional disorder of stroke patients,” Journal of Korean Academy of RehabilitationMedicine, vol. 12, pp. 33–38, 1995.pl_PL
dc.referencesA. Pan, Q. Sun, O. I. Okereke, K. M. Rexrode, and F. B. Hu, “Depression and risk of stroke morbidity andmortality: a metaanalysis and systematic review,” The Journal of the American Medical Association, vol. 306, no. 11, pp. 1241–1249, 2011.pl_PL
dc.referencesC. Ellis, Y. Zhao, and L. E. Egede, “Depression and increased risk of death in adults with stroke,” Journal of Psychosomatic Research, vol. 68, no. 6, pp. 545–551, 2010.pl_PL
dc.referencesP. Masskulpan, K. Riewthong, P. Dajpratham, and V. Kuptniratsaikul, “Anxiety and depressive symptoms after stroke in 9 rehabilitation centers,” Journal of the Medical Association of Thailand, vol. 91, no. 10, pp. 1595–1602, 2008.pl_PL
dc.referencesS. Paolucci, “Epidemiology and treatment of post-stroke depression,” Neuropsychiatric Disease and Treatment, vol. 4, no. 1, pp. 145–154, 2008.pl_PL
dc.referencesN. Hadidi, D. J. Treat-Jacobson, and R. Lindquist, “Poststroke depression and functional outcome: a critical review of literature,” Heart and Lung, vol. 38, no. 2, pp. 151–162, 2009.pl_PL
dc.referencesF. Ng,M.Berk, O. Dean, andA. I. Bush, “Oxidative stress inpsychiatric disorders: evidence base and therapeutic implications,” International Journal of Neuropsychopharmacology, vol. 11, no. 6, pp. 851–876, 2008.pl_PL
dc.referencesD. Radak, I. Resanovic, and E. R. Isenovic, “Link between oxidative stress and acute brain ischemia,” Angiology, vol. 65, no. 8, pp. 667–676, 2014.pl_PL
dc.referencesE. Miller, A.Walczak, J. Saluk, M. B. Ponczek, and I. Majsterek, “Oxidative modification of patient’s plasma proteins and its role in pathogenesis ofmultiple sclerosis,” Clinical Biochemistry, vol. 45, no. 1-2, pp. 26–30, 2012.pl_PL
dc.referencesM. Maes, P. Galecki, Y. S. Chang, and M. Berk, “A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 676–692, 2011.pl_PL
dc.referencesM. Maes, “An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 784–794, 2011.pl_PL
dc.referencesH. Suzuki and M. Colasanti, “NO: a molecule with two masks of ‘NO’ theatre,” BioFactors, vol. 15, no. 2–4, pp. 123–125, 2001.pl_PL
dc.referencesA.Dhir and S. K. Kulkarni, “Nitric oxide andmajor depression,” Nitric Oxide, vol. 24, no. 3, pp. 125–131, 2011.pl_PL
dc.referencesJ. W. Gawryluk, J. F. Wang, A. C. Andreazza, L. Shao, and L. T. Young, “Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders,” International Journal of Neuropsychopharmacology, vol. 14, no. 1, pp. 123–130, 2011.pl_PL
dc.referencesS.-Y. Lee, S.-J. Lee, C. Han, A. A. Patkar, P. S. Masand, and C.- U. Pae, “Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 46, pp. 224–235, 2013pl_PL
dc.referencesW. Drȫge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002.pl_PL
dc.referencesK. Uchida and E. R. Stadtman, “Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. Apossible involvement of intra- and intermolecular crosslinking reaction,” The Journal of Biological Chemistry, vol. 268, no. 9, pp. 6388–6393, 1993.pl_PL
dc.referencesW. Li, C. Busu, M. L. Circu, and T. Y. Aw, “Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis,” International Journal ofCell Biology, vol. 2012,Article ID 434971, 14 pages, 2012.pl_PL
dc.referencesY.Wang, J. Yang, and J. Yi, “Redox sensing by proteins: oxidative modifications on cysteines and the consequent events,” Antioxidants and Redox Signaling, vol. 16, no. 7, pp. 649–657, 2012.pl_PL
dc.referencesJ. Sun and E.Murphy, “Protein S-nitrosylation and cardioprotection,” Circulation Research, vol. 106, no. 2, pp. 285–296, 2010.pl_PL
dc.referencesB. N. Manolescu, M. Berteanu, E. Oprea et al., “Dynamic of oxidative andnitrosative stressmarkersduring the convalescent period of stroke patients undergoing rehabilitation,” Annals of Clinical Biochemistry, vol. 48, no. 4, pp. 338–343, 2011.pl_PL
dc.referencesC. D. Reiter, R.-J. Teng, and J. S. Beckman, “Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite,”The Journal of Biological Chemistry, vol. 275, no. 42, pp. 32460–32466, 2000.pl_PL
dc.referencesI. M. Cojocaru, M. Cojocaru, V. Sapira, and A. Ionescu, “Evaluation of oxidative stress in patients with acute ischemic stroke,” Romanian Journal of Internal Medicine, vol. 51, no. 2, pp. 97–106, 2013.pl_PL
dc.referencesT. R.Golden andM. Patel, “Catalytic antioxidants and neurodegeneration,” Antioxidants & Redox Signaling, vol. 11, no. 3, pp. 555–569, 2009.pl_PL
dc.referencesH. Buss, T. P. Chan, K. B. Sluis, N. M. Domigan, and C. C. Winterbourn, “Protein carbonyl measurement by a sensitive ELISA method,” Free Radical Biology and Medicine, vol. 23, no. 3, pp. 361–366, 1997.pl_PL
dc.referencesD. H. Alamdari, E. Kostidou, K. Paletas et al., “High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein,” Free Radical Biology and Medicine, vol. 39, no. 10, pp. 1362–1367, 2005.pl_PL
dc.referencesM. Bijak, J. Kolodziejczyk-Czepas, M. B. Ponczek, J. Saluk, and P.Nowak, “Protective effects of grape seed extract against oxidative and nitrative damage of plasma proteins,” International Journal of Biological Macromolecules, vol. 51, no. 3, pp. 183–187, 2012.pl_PL
dc.referencesJ. F. Koster, P. Biemond, and A. J. G. Swaak, “Intracellular and extracellular sulphydryl levels in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 45, no. 1, pp. 44–46, 1986.pl_PL
dc.referencesJ. Khan, D. M. Brennand, N. Bradley, B. Gao, R. Bruckdorfer, and M. Jacobs, “3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method,” Biochemical Journal, vol. 330, part 2, pp. 795–801, 1998.pl_PL
dc.referencesH. Ischiropoulos and A. B. Al-Mehdi, “Peroxynitrite-mediated oxidative protein modifications,” FEBS Letters, vol. 364, no. 3, pp. 279–282, 1995.pl_PL
dc.referencesR. F. Beers Jr. and I. W. Sizer, “A spectrophotometric method formeasuring the breakdown of hydrogen peroxide by catalase,” The Journal of Biological Chemistry, vol. 195, no. 1, pp. 133–140, 1952.pl_PL
dc.referencesW. R. Wallace and G. T. Dimopoullos, “Catalase activity in anaplasma marginale,” Journal of Bacteriology, vol. 90, pp. 309– 311, 1965.pl_PL
dc.referencesJ. Hauke and T. Kossowski, “Comparison of values of pearson’s and spearman’s correlation coefficients on the same sets of data,” Quaestiones Geographicae, vol. 30, no. 2, pp. 87–93, 2011.pl_PL
dc.referencesE. M. Whyte and B. H. Mulsant, “Post stroke depression: epidemiology, pathophysiology, and biological treatment,” Biological Psychiatry, vol. 52, no. 3, pp. 253–264, 2002.pl_PL
dc.referencesM.-L. Kauhanen, J. T. Korpelainen, P. Hiltunen et al., “Poststroke depression correlates with cognitive impairment and neurological deficits,” Stroke, vol. 30, no. 9, pp. 1875–1880, 1999.pl_PL
dc.referencesK. Narushima, K.-L. Chan, J. T. Kosier, and R. G. Robinson, “Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression,”TheAmerican Journal of Psychiatry, vol. 160, no. 6, pp. 1157–1162, 2003.pl_PL
dc.referencesH. Tiemeier, “Biological risk factors for late life depression,” European Journal of Epidemiology, vol. 18, no. 8, pp. 745–750, 2003.pl_PL
dc.referencesW. K. Tang, H. Liang, W. C. W. Chu, V. Mok, G. S. Ungvari, and K. S. Wong, “Association between high serum total bilirubin and post-stroke depression,” Psychiatry and Clinical Neurosciences, vol. 67, no. 4, pp. 259–264, 2013.pl_PL
dc.referencesL. Yang, Z. Zhang, D. Sun, Z. Xu, X. Zhang, and L. Li, “The serum interleukin-18 is a potential marker for development of post-stroke depression,” Neurological Research, vol. 32,no. 4, pp. 340–346, 2010.pl_PL
dc.referencesL. S. Rothenburg, N. Herrmann, W. Swardfager et al., “The relationship between inflammatory markers and post stroke cognitive impairment,” Journal of Geriatric Psychiatry and Neurology, vol. 23, no. 3, pp. 199–205, 2010.pl_PL
dc.referencesA. B.Gold,N.Herrmann,W. Swardfager et al., “The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment,” Journal of Neuroinflammation, vol. 8, article 17, 2011.pl_PL
dc.referencesJ.Huppert,D.Closhen, A. Croxford et al., “Cellularmechanisms of IL-17-induced blood-brain barrier disruption,” The FASEB Journal, vol. 24, no. 4, pp. 1023–1034, 2010.pl_PL
dc.referencesW. Swardfager,N.Herrmann, A. C. Andreazza et al., “Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stress,” BioMed Research International, vol. 2014,Article ID 245210, 6 pages, 2014.pl_PL
dc.referencesB. Halliwell, “Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life,” Plant Physiology, vol. 141, no. 2, pp. 312–322, 2006.pl_PL
dc.referencesR. H. Belmaker and G. Agam, “Major depressive disorder,” The NewEngland Journal ofMedicine, vol. 358, no. 1,pp. 55–68, 2008.pl_PL
dc.referencesY.Dowlati,N.Herrmann,W. Swardfager et al., “A meta-analysis of cytokines in major depression,” Biological Psychiatry, vol. 67, no. 5, pp. 446–457, 2010.pl_PL
dc.referencesC. P. Chung, D. Schmidt, C. M. Stein, J. D. Morrow, and R. M. Salomon, “Increased oxidative stress in patientswith depression and its relationship to treatment,” Psychiatry Research, vol. 206, no. 2-3, pp. 213–216, 2013.pl_PL
dc.referencesA. Vogelgesang and A. Dressel, “Immunological consequences of ischemic stroke: Immunosuppression and autoimmunity,” Journal of Neuroimmunology, vol. 231, no. 1-2, pp. 105–110, 2011.pl_PL
dc.referencesA. R. Pachner, “Neuroimmunology of degenerative diseases and stroke ,” in A Primer of Neuroimmunological Disease, pp. 155– 158, Springer, Boston,Mass, USA, 2012.pl_PL
dc.referencesC.-U. Pae, H.-S. Yu, T.-S.Kimet al., “Monocyte chemoattractant protein-1 (MCP1) promoter-2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population,” Psychiatry Research, vol. 127, no. 3, pp. 279–281, 2004.pl_PL
dc.referencesC.-U. Pae, D. M. Marks, C. Han, A. A. Patkar, and D. Steffens, “Does neurotropin-3 have a therapeutic implication in major depression?” International Journal of Neuroscience, vol. 118, no. 11, pp. 1515–1522, 2008.pl_PL
dc.referencesA. Berg, J. L¨onnqvist, H. Palom¨aki, and M. Kaste, “Assessment of depression after stroke a comparison of different screening instruments,” Stroke, vol. 40, no. 2, pp. 523–529, 2009pl_PL
dc.referencesE. R. Stadtman and R. L. Levine, “Free radical-mediated oxidation of free amino acids and amino acid residues in proteins,” Amino Acids, vol. 25, no. 3-4, pp. 207–218, 2003.pl_PL
dc.referencesK. Safwen, S. Selima, E. Mohamed et al., “Protective effect of grape seed and skin extract on cerebral ischemia in rat: implication of transitionmetals,” International Journal of Stroke, 2014.pl_PL
dc.referencesH.-Z. Chen, S. Guo, Z.-Z. Li et al., “A critical role for interferon regulatory factor 9 in cerebral ischemic stroke,” Journal of Neuroscience, vol. 34, no. 36, pp. 11897–11912, 2014.pl_PL
dc.referencesA. A. Abd-Elsameea, A. A. Moustaf, and A. M. Mohamed, “Modulation of the oxidative stress by metformin in the cerebrum of rats exposed to global cerebral ischemia and ischemia/reperfusion,” European Review for Medical and Pharmacological Sciences, vol. 18, no. 16, pp. 2387–2392, 2014.pl_PL
dc.referencesJ.-C. Lee and M.-H. Won, “Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils,” Anatomy & Cell Biology, vol. 47, no. 3, pp. 149–156, 2014.pl_PL
dc.referencesL. Doma´nski, B. Dołegowska, K. Safranow et al., “Early phase of reperfusion of human kidney allograft does not affect an erythrocyte anti-oxidative system,” Nephrology, vol. 11,no. 5, pp. 467–470, 2006.pl_PL
dc.referencesB. R. S. Broughton, D. C. Reutens, and C. G. Sobey, “Apoptotic mechanisms after cerebral ischemia,” Stroke, vol. 40, no. 5, pp. e331–e339, 2009.pl_PL
dc.referencesI. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, and R. Colombo, “Protein carbonyl groups as biomarkers of oxidative stress,” Clinica Chimica Acta, vol. 329, no. 1-2, pp. 23–38, 2003.pl_PL
dc.referencesZ. Wang, T. Liu, L. Gan et al., “Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity,” European Journal of Pharmacology, vol. 643, no. 2-3, pp. 211–217, 2010.pl_PL
dc.referencesB. Groitl andU. Jakob, “Thiol-based redox switches,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1844,no. 8, pp. 1335–1343, 2014.pl_PL
dc.referencesN.-W. Tsai, Y.-T. Chang, C.-R. Huang et al., “Association between oxidative stress and outcome in different subtypes of acute ischemic stroke,” BioMed Research International, vol. 2014, Article ID 256879, 7 pages, 2014.pl_PL
dc.referencesF. Wang, W. Liang, C. Lei et al., “Combination of HBO and memantine in focal cerebral ischemia: is there a synergistic effect?” Molecular Neurobiology, 2014.pl_PL
dc.referencesM. Bijak, M. Ponczek, J. Saluk, M. Chabielska, J. Stepniak, and P. Nowak, “Peroxynitrite a strong biological oxidant,” Chemical News, vol. 66, 2012.pl_PL
dc.referencesN.W.Kooy, J. A. Royall,Y. Z.Ye, D. R. Kelly, and J. S. Beckman, “Evidence for in vivo peroxynitrite production in human acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 4, pp. 1250–1254, 1995.pl_PL
dc.referencesN. Fukuyama, Y. Takebayashi, M. Hida, H. Ishida, K. Ichimori, andH.Nakazawa, “Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock,” Free Radical Biology and Medicine, vol. 22, no. 5, pp. 771–774, 1997.pl_PL
dc.referencesY. Hayashi, Y. Sawa, M. Nishimura et al., “Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response,” European Journal of Cardio-Thoracic Surgery, vol. 26, no. 2, pp. 276–280, 2004.pl_PL
dc.referencesD. Salvemini and S. Cuzzocrea, “Oxidative stress in septic shock and disseminated intravascular coagulation,” Free Radical Biology and Medicine, vol. 33, no. 9, pp. 1173–1185, 2002.pl_PL
dc.referencesC. Szab´o, “Multiple pathways of peroxynitrite cytotoxicity,” Toxicology Letters, vol. 140-141, pp. 105–112, 2003.pl_PL
dc.referencesM. Hoffman, “Alterations of fibrinogen structure in human disease,” Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 6, no. 3, pp. 206–211, 2008.pl_PL
dc.referencesC. Vadseth, J. M. Souza, L. Thomson et al., “Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species,” The Journal of Biological Chemistry, vol. 279, no. 10, pp. 8820–8826, 2004.pl_PL
dc.referencesD. F. Bas, M. A. Topcuoglu, Y. Gursoy-Ozdemir, I. Saatci, E. Bodur, and T. Dalkara, “Plasma 3-nitrotyrosine estimates the reperfusion-induced cerebrovascular stress, whereas matrix metalloproteinases mainly reflect plasma activity: a study in patients treated with thrombolysis or endovascular recanalization,” Journal ofNeurochemistry, vol. 123, no. 2,pp. 138–147, 2012.pl_PL
dc.referencesM. Coucha, W. Li, M. H. Johnson, S. C. Fagan, and A. Ergul, “Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 12, pp. H1726–H1735, 2013.pl_PL
dc.referencesM. Tajes, G. Ill-Raga, E. Palomer et al., “Nitro-oxidative stress after neuronal ischemia induces protein nitrotyrosination and cell death,” OxidativeMedicine and Cellular Longevity, vol. 2013, Article ID 826143, 9 pages, 2013.pl_PL
dc.referencesD. Venarucci, V. Venarucci, A. Vallese et al., “Free radicals: important cause of pathologies refer to ageing,” Panminerva Medica, vol. 41, pp. 335–339, 1999.pl_PL
dc.referencesE. Miller, M. Mrowicka, K. Malinowska, J. Mrowicki, J. Saluk- Juszczak, and J. Kedziora, “Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients,” World Journal of Biological Psychiatry, vol. 12,no. 3, pp. 223–227, 2011.pl_PL
dc.identifier.doi10.1155/2015/408745


Files in this item

Thumbnail
Name:
Postroke.pdf
Size:
1.581Mb
Format:
PDF
View/Open
Thumbnail
Name:
license_rdf
Size:
1.337Kb
Format:
application/rdf+xml
View/Open

This item appears in the following Collection(s)

Show simple item record

Uznanie autorstwa 3.0 Polska
Except where otherwise noted, this item's license is described as Uznanie autorstwa 3.0 Polska